PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-04-08

Date Title Company
08-Apr-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
08-Apr-2020 Aridis Pharmaceuticals Announces 2019 Fourth Quarter and Year-End Financial Results and Business Update Aridis Pharmaceuticals, Inc.
08-Apr-2020 Celltrion Healthcare secure 300 COVID-19 antibody candidates in efforts to develop antiviral Celltrion Healthcare
08-Apr-2020 Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million Santhera
08-Apr-2020 Biovica initiates a collaboration with Mayo Clinic to study DiviTum® for the on-treatment monitoring of metastatic breast cancer patients receiving CDK 4/6 inhibitors Biovica
08-Apr-2020 90TEN acquired by Envision Pharma Group Envision Pharma Group
08-Apr-2020 Immutep’s partner, EOC Pharma, to continue advancing Efti in breast cancer Immutep
08-Apr-2020 Chiesi Group increases support measures and announces new funds for employees, patients and healthcare providers in response to COVID-19 pandemic Chiesi Group
08-Apr-2020 FDA Approves First Generic of a Commonly Used Albuterol Inhaler to Treat and Prevent Bronchospasm U.S. Food and Drug Administration
08-Apr-2020 Mylan Updates Its Efforts Regarding COVID-19 Mylan N.V.
08-Apr-2020 Quell Therapeutics Enters a Collaborative Research Agreement with the Hannover Medical School Quell Therapeutics
08-Apr-2020 Réf. DC 058(2020) COVID-19: How to protect yourself from falsified medical products? MEDICRIME Committee
08-Apr-2020 Lamellar Biomedical launches program designed to prevent the severe respiratory effects of COVID-19, using its unique LAMELLASOME™ Technology Lamellar Biomedical
08-Apr-2020 The Life Sciences Sector Post-Brexit (So Far) UK life sciences
08-Apr-2020 Amphista Therapeutics raises $7.5m Series A round to advance targeted protein degradation assets in cancer Amphista Therapeutics
08-Apr-2020 Santhera Enters into Equity-linked Financing to Provide up to CHF 12 million with the Option to Increase to up to CHF 24 million Santhera Pharmaceuticals
08-Apr-2020 Almac Clinical Technologies Announces Expedited Support for COVID-19 Clinical Trials Almac Group
08-Apr-2020 COVID-19: BOLLORÉ LOGISTICS RECEIVES 92 TONS OF PROTECTIVE MASKS AND MEDICAL EQUIPMENT FROM CHINA AT THE GENEVA AIRPORT Bolloré Logistics
08-Apr-2020 (2020-2025) Hospital Beds Market Is Booming Worldwide| Global Industry Size, Growth, Segments, Revenue, Manufacturers Alexa Reports
08-Apr-2020 Market Size of CAR T-Cell Therapy for Multiple Myeloma in the 6MM is Expected to Be USD 3,766.4 Million in 2030 | Some of the Major Players Involved Are Celgene Corporation, Janssen Research & Development, Poseida Therapeutics, MolMed S.p.A., Cartesian Therapeutics, Precision BioSciences DelveInsight Business Research, LLP